WOBURN, Mass (April 2)—CardioTech International Inc. will complete the acquisition of Gish Biomedical Inc. April 7 for about $7.6 million in stock, ending several months of discussions between the two medical product manufacturers. The acquisition provides CardioTech, headquartered in Woburn, with a leadership presence in the high-visibility open-heart surgery field and advances its strategy of expanding the breadth of Food and Drug Administration-cleared products it provides to hospitals, CardioTech CEO Michael Szycher said. Rancho Santa Margarita, Calif.-based Gish's large clean-room facility will give CardioTech the resources necessary to expand its manufacturing operation, he said.
CardioTech, Gish complete deal
Rubber & Plastics News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].